Anti-EEF2/Elongation factor 2 (phospho T56 + T58) antibody [EP833Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications )
- WB
Unknown
Western blot - Anti-EEF2/Elongation factor 2 (phospho T56 + T58) antibody [EP833Y] (AB82981)
All lanes:
Western blot - Anti-EEF2/Elongation factor 2 (phospho T56 + T58) antibody [EP833Y] (ab82981) at 1/2000 dilution
Lane 1:
Untreated 293 cell lysate at 10 µg
Lane 2:
Serum starved 293 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 95 kDa
Observed band size: 95 kDa
false
Related conjugates and formulations (1)
-
Anti-EEF2/Elongation factor 2 (phospho T56 + T58) antibody [EP833Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EEF2 functions as part of a larger ribosomal complex. It has an important role in ensuring the accuracy and efficiency of elongation during the translation process. This process is energy-dependent with EEF2 requiring GTP to catalyze the movement along the mRNA strand. The protein must undergo reversible phosphorylation which directly affects its activity. This post-translational modification of EEF2 is a significant modulation point influencing the rate of protein synthesis.
Pathways
EEF2 plays an integral role in the mTOR signaling pathway and the insulin signaling pathway. In the mTOR pathway EEF2 activity is regulated to control protein translation based on cellular energy status and nutrient availability. This pathway is important for cell growth and proliferation. EEF2 interacts with other proteins such as factor 2 and eEF2kinase which phosphorylates the protein thereby inhibiting its activity. In the insulin signaling pathway similar regulatory mechanisms impact EEF2’s role in translation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Cell discovery 11:58 PubMed40555714
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science translational medicine 11: PubMed31619542
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature 558:435-439 PubMed29899451
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 289:23901-16 PubMed25012662
2014
Applications
Unspecified application
Species
Human
The Journal of physiology 589:3623-40 PubMed21606113
2011
Applications
WB
Species
Mouse
Biochimica et biophysica acta 1814:850-7 PubMed21513824
2011
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com